Respiratory Medicine
Volume 104, Issue 7 , Pages 981-985, July 2010

Trends in bronchiectasis mortality in England and Wales

  • Helen J. Roberts

      Affiliations

    • Nottingham University Hospitals NHS Trust, United Kingdom
    • Corresponding Author InformationCorresponding author at: Respiratory Medicine, David Evans Building, City Hospital, Hucknall Road, Nottingham NG15 1PB. Tel.: +44 115 9691169; fax: +44 115 8404771.
  • ,
  • Richard Hubbard

      Affiliations

    • Division of Epidemiology and Public Health, University of Nottingham, United Kingdom

Received 9 September 2009; accepted 22 February 2010. published online 22 March 2010.

Summary 

Background

To provide information on the burden of bronchiectasis in England and Wales, we have examined trends in mortality using death certificate data available from the Office of National Statistics.

Methods

We extracted data on deaths due to non-cystic fibrosis bronchiectasis for 2001–2007 inclusive and stratified deaths by sex and age group. We used Poisson regression to compare mortality rates.

Results

Between 2001 and 2007, 5745 bronchiectasis related deaths were registered in England and Wales. When standardized to the 2007 population, this showed a rise in absolute numbers from 797 (2001) to 908 (2007). Statistical analyses suggested that the mortality rate is currently increasing at 3%/year (p < 0.001). Mortality rates were similar between men and women but there was a strong statistical interaction between age group and year (p < 0.001) Rates were increasing in the two oldest age groups but falling in the three youngest groups.

Discussion

Currently just under 1000 people die from bronchiectasis each year in England and Wales. We found the number of deaths to be increasing at 3% per year. Although overall mortality was increasing, rates were increasing in older groups but falling in the younger groups.

These mortality rates may underestimate the burden of disease from bronchiectasis as lack of knowledge about the disease may lead to underreporting. These are also mortality rather than incidence data and may reflect improvements in treatment.

Bronchiectasis therefore remains a significant concern. Clinical provision will potentially need to increase in order to care for this patient group.

Keywords: Bronchiectasis, Mortality, Burden of disease

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0954-6111(10)00092-2

doi:10.1016/j.rmed.2010.02.022

Respiratory Medicine
Volume 104, Issue 7 , Pages 981-985, July 2010